Form 4: Hinge Health Director's Fund Sells Shares

Sentiment:

Insider Transaction Report


A director and 10% owner of Hinge Health, Elliott Robinson, reported an indirect sale of Class A Common Stock by Bessemer Venture Partners funds.

Summary

  • Elliott Robinson, a Director and 10% Owner of Hinge Health, Inc. (HNGE), reported an indirect sale of Class A Common Stock.
  • The transaction occurred on December 5, 2025.
  • Bessemer Venture Partners X L.P. and Bessemer Venture Partners X Institutional L.P. (Bessemer Funds) sold a total of 5,067 shares.
  • The shares were sold at a weighted average price of $50.0166, with prices ranging from $50.00 to $50.12.
  • Robinson is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds.
  • Robinson disclaims beneficial ownership of these securities except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: Neutral. While an insider sale can sometimes be perceived negatively, this is an indirect sale by a venture capital fund, which is a common part of their investment lifecycle. The reporting person also disclaims direct beneficial ownership, mitigating personal sentiment.

Negatives

  • An indirect sale of 5,067 shares of Class A Common Stock by funds associated with a director and 10% owner.

Future Outlook

NA

Management Comments

  • The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds.
  • This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities.

Industry Context

This Form 4 filing reports a routine insider transaction by a venture capital fund associated with a director, which is common as funds mature and seek liquidity for their limited partners. It does not provide broader industry context or trends.

Related Party Transactions

  • The sale was conducted by Bessemer Venture Partners funds, where the reporting person, Elliott Robinson, is a partner and holds an indirect economic interest.

Stakeholder Impact

  • Shareholders may observe the indirect sale by a director and 10% owner, which could be interpreted in various ways depending on market sentiment and the broader context of the company's performance.

Next Steps

  • The reporting person undertakes to provide full information regarding the number of shares sold at each separate price within the stated ranges upon request to the Issuer, any security holder, or the SEC staff.

Key Dates

DateDescription
12/05/2025Date of earliest transaction (sale of Class A Common Stock)
12/09/2025Signature date of the reporting person's attorney-in-fact

Keywords

Hinge Health, HNGE, SEC Form 4, Insider Trading, Stock Sale, Bessemer Venture Partners, Director Transaction, 10% Owner

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.